Insurance Learning Pharmaceutical 
Insperity
AUGUST 9, 2018
When the mandates of the Affordable Care Act hit the marketplace in 2013, for example, insurance brokers nationwide were challenged with delivering additional value to their customers to offset rising healthcare costs for employers. A strategy for success.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Was it related to medical insurance or government programs? Society is saying, “Wow, we’re learning so much from brain research.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
DECEMBER 18, 2023
Finally, physicians learned that bed rest was the worst thing that one can do for back pain. Certainly, most physicians would fight against such a policy, as would the health insurance companies, health plan designers, managed care executives, most healthcare consultants and others as well.
Virgin Pulse Corporate Wellness
DECEMBER 14, 2023
Commercially insured high-cost claimants represent nearly a third of all healthcare spending, even though they are only 1.2% of commercial health insurance enrollees. This does not even account for medical and pharmaceutical costs. According to the American Health Policy Institute , their costs average $122,382 annually – 29.3
Ask a Manager
MARCH 27, 2017
Even though he left on awful terms, I do want to see him do well, learn, and grow from his experience with us. I feel very disgruntled and disrespected and it’s hard to be the only one without insurance, salary, or benefits (besides the younger intern). Would declining a reference call be a red flag to a company?
Mad in America
JANUARY 6, 2024
One advantage of BetterHelp is that because the service does not bill insurance, there is no need for clinicians to provide a diagnosis and target therapy to fit the “medical necessity” requirements imposed by third-party payers. But critics contend that treatments provided in research settings are artificial.
Mad in America
DECEMBER 13, 2023
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. There is this growing grassroots resistance.
Expert insights. Personalized for you.
221 
Let's personalize your content